Brookdale Senior Living Inc.
BKD NYSE Services-Nursing & Personal Care Facilities Financials FY2016βFY2025
What Brookdale Senior Living Inc. does
No business description yet.
- Legal name
- Brookdale Senior Living Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 19, 2026
- Accession Β· CIK
- 0001332349-26-000032
0001332349
Revenue and margins
Brookdale Senior Living Inc. had $3.2B of revenue in fiscal 2025, up 2.2% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $16.5M in fiscal 2025, 0.5% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Brookdale Senior Living Inc. returned β to shareholders in fiscal 2025. The diluted share count rose 3.4%.
Balance sheet
Cash, debt and the ratios that show how comfortably Brookdale Senior Living Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $529M | $448M | $308M | $329M | $279M |
| Debt incl. finance leases | $4.4B | $4.1B | $3.8B | $4.4B | $4.3B |
| Net debt / EBITDA | 30.2x | 11.7x | 9.6x | 9.8x | 10.5x |
| Debt / equity | 5.5x | 6.6x | 9.2x | 19.1x | β |
| Interest coverage | β1.1x | β0.2x | 0.1x | 0.2x | β |
| Current ratio | 1.1x | 1.0x | 0.8x | 0.9x | 1.0x |
| Quick ratio | 1.1x | 1.0x | 0.8x | 0.9x | 1.0x |
| Total assets | $6.4B | $5.9B | $5.6B | $6.3B | $6.0B |
| Total liabilities | $5.7B | $5.4B | $5.2B | $6.1B | $6.0B |
| Shareholders' equity | $697M | $583M | $404M | $212M | β$44.8M |
| Net debt (β = net cash) | $3.9B | $3.7B | $3.5B | $4.0B | $4.0B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 3 / 9 | 5 / 9 | 5 / 9 | 7 / 9 | 1 / 9 | 4 / 9 | 5 / 9 | 6 / 9 | 5 / 9 |
| Accruals ratio | β8.4% | β11.2% | β10.4% | β7.1% | β1.8% | β0.1% | β3.9% | β6.1% | β6.2% | β7.8% |
| Altman Z'' | β0.49 | β1.22 | β1.97 | β1.88 | β1.44 | β1.77 | β1.94 | β2.28 | β2.06 | β2.36 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $5.0B | $4.7B | $4.5B | $4.1B | $3.5B | $2.8B | $2.8B | $3.0B | $3.1B | $3.2B |
| Gross profit | $1.4B | $1.3B | $1.1B | $877M | $797M | $501M | $594M | $747M | $799M | $838M |
| Operating income | β$31.1M | β$270M | β$594M | β$44.5M | β$97.7M | β$217M | β$42.7M | $18.4M | $46.5M | $13.5M |
| Interest expense | $386M | $326M | $280M | $248M | $209M | $195M | $205M | $238M | $253M | β |
| Pretax income | β$399M | β$588M | β$578M | β$271M | $87.3M | β$108M | β$240M | β$180M | β$197M | β$265M |
| Income tax | $5.4M | β$16.5M | β$49.5M | β$2.3M | $5.4M | β$8.2M | β$1.6M | $8.8M | $4.6M | β$2.0M |
| Net income | β$404M | β$571M | β$528M | β$268M | $82.0M | β$99.3M | β$238M | β$189M | β$202M | β$263M |
| Diluted EPS | β$2.18 | β$3.07 | β$2.82 | β$1.44 | $0.44 | β$0.54 | β$1.25 | β$0.84 | β$0.89 | β$1.12 |
| Diluted shares | 0.19B | 0.19B | 0.19B | 0.19B | 0.18B | 0.18B | 0.19B | 0.23B | 0.23B | 0.24B |
| Cash flow | ||||||||||
| Cash from operations | $374M | $378M | $204M | $216M | $206M | β$94.6M | $3.3M | $163M | $166M | $218M |
| Capital expenditure | $334M | $214M | $225M | $304M | $186M | $177M | $197M | $233M | $201M | $202M |
| Free cash flow | $40.0M | $164M | β$21.5M | β$87.7M | $19.8M | β$271M | β$194M | β$70.3M | β$35.1M | $16.5M |
| Depreciation and amortization | $530M | $495M | $456M | $384M | $365M | $345M | $354M | $350M | $368M | $370M |
| Stock-based compensation | $32.3M | $27.8M | $26.1M | $23.0M | $20.7M | $16.3M | $14.5M | $12.0M | $14.2M | $11.9M |
| Acquisitions | $12.2M | $5.2M | β | β | β | β | β | β | β | β |
| Share buybacks | $9.6M | $0.0M | $4.3M | $24.0M | $18.1M | $0.0M | $0.0M | β | β | β |
| Dividends and buybacks | $9.6M | $0.0M | $4.3M | $24.0M | $18.1M | $0.0M | $0.0M | β | β | β |
| Balance sheet | ||||||||||
| Cash and short-term investments | $216M | $514M | $413M | $309M | $553M | $529M | $448M | $308M | $329M | $279M |
| Total debt | $6.0B | $5.1B | $3.6B | $3.6B | $3.9B | $3.8B | $3.9B | $3.7B | $4.1B | $4.3B |
| Finance lease liabilities | β | β | β | $835M | $563M | $554M | $249M | $152M | $304M | $25.6M |
| Current assets | $620M | $902M | $774M | $596M | $774M | $699M | $637M | $478M | $513M | $554M |
| Current liabilities | $731M | $1.1B | $773M | $1.0B | $691M | $632M | $641M | $600M | $580M | $568M |
| Property and equipment, net | $7.4B | $5.9B | $5.3B | β | β | β | β | β | β | β |
| Goodwill | $705M | $506M | $154M | $154M | $154M | $27.3M | $27.3M | $27.3M | $27.3M | $27.3M |
| Intangible assets | $83.0M | $68.0M | $51.5M | $35.2M | $34.1M | β | β | β | β | β |
| Total assets | $9.2B | $7.7B | $6.5B | $7.2B | $6.9B | $6.4B | $5.9B | $5.6B | $6.3B | $6.0B |
| Total liabilities | $7.1B | $6.1B | $5.4B | $6.5B | $6.1B | $5.7B | $5.4B | $5.2B | $6.1B | $6.0B |
| Preferred stock | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $2.1B | $1.5B | $1.0B | $696M | $800M | $697M | $583M | $404M | $212M | β$44.8M |
| Margins | ||||||||||
| Gross margin | 28.9% | 26.4% | 23.6% | 21.6% | 22.5% | 18.2% | 21.0% | 24.8% | 25.6% | 26.2% |
| Operating margin | β0.6% | β5.7% | β13.1% | β1.1% | β2.8% | β7.9% | β1.5% | 0.6% | 1.5% | 0.4% |
| EBITDA margin | 10.0% | 4.7% | β3.1% | 8.4% | 7.6% | 4.6% | 11.0% | 12.2% | 13.2% | 12.0% |
| Net margin | β8.1% | β12.0% | β11.7% | β6.6% | 2.3% | β3.6% | β8.4% | β6.3% | β6.5% | β8.2% |
| FCF margin | 0.8% | 3.5% | β0.5% | β2.2% | 0.6% | β9.8% | β6.9% | β2.3% | β1.1% | 0.5% |
| Returns | ||||||||||
| Return on capital | β0.3% | β3.5% | β11.1% | β0.9% | β2.2% | β4.3% | β0.8% | 0.4% | 0.9% | 0.3% |
| Return on capital employed | β0.4% | β4.1% | β10.4% | β0.7% | β1.6% | β3.8% | β0.8% | 0.4% | 0.8% | 0.3% |
| Return on equity | β19.5% | β31.7% | β41.4% | β31.2% | 11.0% | β13.3% | β37.3% | β38.3% | β65.5% | β313.2% |
| Return on assets | β4.4% | β6.8% | β7.5% | β3.9% | 1.2% | β1.5% | β3.9% | β3.3% | β3.4% | β4.3% |
| Return on tangible equity | β31.4% | β59.7% | β65.0% | β52.8% | 13.4% | β14.8% | β42.9% | β50.2% | β109.1% | β |
| Growth | ||||||||||
| Revenue growth | β | β4.6% | β4.5% | β10.5% | β12.7% | β22.1% | 2.4% | 6.7% | 3.6% | 2.2% |
| Net income growth | β | β | β | β | β | β221.1% | β | β | β | β |
| EPS growth | β | β | β | β | β | β222.7% | β | β | β | β |
| FCF growth | β | 311.1% | β113.1% | β | β | β1,471.7% | β | β | β | β |
| Share count change | β | 0.3% | 0.7% | β0.8% | β0.8% | 0.3% | 3.0% | 18.2% | 1.0% | 3.4% |
| Financial health | ||||||||||
| Net debt / EBITDA | 11.7x | 20.6x | β | 12.0x | 14.7x | 30.2x | 11.7x | 9.6x | 9.8x | 10.5x |
| Debt / equity | 2.9x | 3.4x | 3.6x | 5.1x | 4.9x | 5.5x | 6.6x | 9.2x | 19.1x | β |
| Interest coverage | β0.1x | β0.8x | β2.1x | β0.2x | β0.5x | β1.1x | β0.2x | 0.1x | 0.2x | β |
| Current ratio | 0.8x | 0.8x | 1.0x | 0.6x | 1.1x | 1.1x | 1.0x | 0.8x | 0.9x | 1.0x |
| Quick ratio | 0.8x | 0.8x | 1.0x | 0.6x | 1.1x | 1.1x | 1.0x | 0.8x | 0.9x | 1.0x |
| Capital allocation | ||||||||||
| Capex / revenue | 6.7% | 4.5% | 5.0% | 7.5% | 5.3% | 6.4% | 7.0% | 7.7% | 6.4% | 6.3% |
| Stock comp / revenue | 0.6% | 0.6% | 0.6% | 0.6% | 0.6% | 0.6% | 0.5% | 0.4% | 0.5% | 0.4% |
| Payouts / FCF | 24.1% | 0.0% | β | β | 91.6% | β | β | β | β | β |
| Quality scores | ||||||||||
| Piotroski F-score | β | 3.0 | 5.0 | 5.0 | 7.0 | 1.0 | 4.0 | 5.0 | 6.0 | 5.0 |
| Altman Z'' | β0.5 | β1.2 | β2.0 | β1.9 | β1.4 | β1.8 | β1.9 | β2.3 | β2.1 | β2.4 |
| Accruals ratio | β8.4% | β11.2% | β10.4% | β7.1% | β1.8% | β0.1% | β3.9% | β6.1% | β6.2% | β7.8% |
Source: SEC EDGAR XBRL filings (CIK 0001332349). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.